By Michael Gwarisa The United States Department of State, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has unveiled a new HIV and AIDS support fund worth US$65.1 million for Zimbabwe. The initiative, known as The Bridge Plan, will run for the next six months, with renewal contingent on the Government of Zimbabwe meeting new U.S. Government (USG) funding requirements. Under the Bridge Plan, the U.S. government will continue to support critical HIV interventions such as antiretroviral therapy (ART) and HIV commodities procurement. However, the new funding excludes certain…
Read MoreTag: HIV treatment
United Nations Proposes Shutting Down UNAIDS In 2026
By Staff Reporter The United Nations (UN) agency focusing on the HIV/AIDS pandemic could close by the end of next year as the UN restructures in the face of a funding crisis, according to a UN document published online. UNAIDS will “sunset” by the end of 2026, the document published on Thursday reads, part of a set of proposals from the UN to member states which they will have to decide on. It adds that UNAIDS’ expertise should be shifted into the wider UN system in the following year. The…
Read MoreZimbabwe Selected Among Ten Countries to Roll Out Breakthrough HIV Prevention Drug, Lenacapavir
By Michael Gwarisa Zimbabwe has been selected as one of ten countries globally to roll out lenacapavir, a revolutionary new HIV prevention drug that is being hailed as a game-changer in the global fight against HIV. The announcement was made on the official U.S. Embassy Zimbabwe Facebook page, marking a historic milestone in the country’s decades-long battle to curb new HIV infections. Lenacapavir, developed by U.S.-based Gilead Sciences in partnership with the Global Fund, is the world’s first twice-yearly HIV prevention medicine. Clinical trial data shows that more than 99%…
Read MoreUNAIDS Welcomes US Move to Expand HIV Prevention Access
By Staff Reporter UNAIDS welcomes the announcement by the US State Department that the President’s Emergency Plan for AIDS Relief (PEPFAR) will be supporting an initiative by the Global Fund to Fight AIDS, TB and Malaria to provide lenacapavir to up to 2 million people in countries with high burdens of HIV. Lenacapavir, an American-based innovation, is one of the most promising new HIV prevention tools that has emerged in the HIV response, offering protection against HIV with just twice-yearly injections. The breakthrough medicine will save thousands of lives if…
Read MoreIn Search For An Elusive HIV Vaccine: Zimbabwean Scientists Dig Deeper For Answers after Imbokodo Trials
By Michael Gwarisa Over the past few years, several interventions have been developed as the world intensifies the fight against HIV and AIDS. These include combined strategies such as behavioral, biomedical, and surgical methods to prevent HIV like Voluntary Medical Male Circumcision (VMMC). For other epidemics such as smallpox, polio, measles and COVID-19, vaccines saved the day as they proved to be efficient tools against the further spread of infections. However, for HIV, it has been a different story altogether. On May 18 every year, the world unites to commemorate World…
Read More